ArticleCancer medicine2020

Combined treatment with N-acetylcysteine and gefitinib overcomes drug resistance to gefitinib in NSCLC cell line.

Jun Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.